CNSP (STOCKS)
CNS Pharmaceuticals, Inc. Common Stock
$5.040000
-0.060000 (-1.18%)
Prev close: $5.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Rami Levin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.53M
- Employees
- 4
- P/E (TTM)
- -0.21
- P/B (TTM)
- 57.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $137.81K |
| Operating Expenses | $16.62M |
| Research and Development | $10.07M |
| Other Operating Expenses | $6.55M |
| Operating Income/Loss | -$16.62M |
| Income/Loss From Continuing Operations After Tax | -$16.49M |
| Income/Loss From Continuing Operations Before Tax | -$16.49M |
| Net Income/Loss | -$16.49M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$16.49M |
| Net Income/Loss Available To Common Stockholders, Basic | -$16.49M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$29.63 |
| Diluted Earnings Per Share | -$29.63 |
| Basic Average Shares | 1,661,988 |
| Diluted Average Shares | 1,661,988 |
| Assets | $4.65M |
| Current Assets | $4.08M |
| Noncurrent Assets | $574.85K |
| Fixed Assets | $22.01K |
| Non-current Prepaid Expenses | $552.84K |
| Liabilities | $4.58M |
| Current Liabilities | $4.58M |
| Noncurrent Liabilities | $0.00 |
| Equity | $70.71K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $70.71K |
| Liabilities And Equity | $4.65M |
| Net Cash Flow From Operating Activities | -$15.22M |
| Net Cash Flow From Operating Activities, Continuing | -$15.22M |
| Net Cash Flow From Investing Activities | $6.56M |
| Net Cash Flow From Investing Activities, Continuing | $6.56M |
| Net Cash Flow From Financing Activities | $5.15M |
| Net Cash Flow From Financing Activities, Continuing | $5.15M |
| Net Cash Flow | -$3.51M |
| Net Cash Flow, Continuing | -$3.51M |
| Comprehensive Income/Loss | -$16.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$16.49M |
| Other Comprehensive Income/Loss | $0.00 |